CLVS
Clovis Oncology, Inc.
CLVS
CLVS
Delisted
CLVS was delisted on the 20th of December, 2022.
255 hedge funds and large institutions have $4.15B invested in Clovis Oncology, Inc. in 2017 Q3 according to their latest regulatory filings, with 43 funds opening new positions, 118 increasing their positions, 63 reducing their positions, and 55 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
22% less first-time investments, than exits
New positions opened: 43 | Existing positions closed: 55
44% less funds holding in top 10
Funds holding in top 10: 16 → 9 (-7)
Holders
255
Holding in Top 10
9
Calls
$178M
Puts
$105M
Top Buyers
| 1 | +$53.6M | |
| 2 | +$53.1M | |
| 3 | +$47.9M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$43.9M |
| 5 |
HM
HealthCor Management
New York
|
+$33.1M |
Top Sellers
| 1 | -$72.3M | |
| 2 | -$58.2M | |
| 3 | -$57.1M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$56.1M |
| 5 |
CCM
Consonance Capital Management
New York
|
-$51M |